Both in Biotechnology
Tenaya Therapeutics vs Atara Biotherapeutics
Over the past year TNYA returned −73.9% and ATRA returned −39.4%; their daily moves had a correlation of 0.11.
TNYA −73.9% ATRA −39.4%Growth of $1, one year, split-adjusted
| Metric | TNYA | ATRA |
|---|---|---|
| Price | $0.3728 | $8.40 |
| Market cap | $85.0M | $84.3M |
| Today | +3.47% | +2.44% |
| 1 month | −31.8% | −13.8% |
| 6 months | −52.8% | +63.1% |
| Year to date | −47.6% | −53.6% |
| 1 year | −73.9% | −39.4% |
| Revenue growth (YoY) | — | −96.4% |
| Gross margin | 100.0% | 69.7% |
| Net margin | −3909.3% | −767.3% |
| P/E (TTM) | — | — |
| Price / sales | 63.6× | 13.6× |
| Net cash | $78.1M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 78.1% | 65.2% |
| Short % of float | 13.1% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).